Objective: The prevalence of phage 80/81 Staphylococcus aureus strains, the pandemic strains that were dominant in the 1950’s had declined in the 1960s and 1970s. However, these strains have re-emerged in some countries in recent years. This study investigated the antibacterial resistance, virulence and the genetic backgrounds of CC30-MSSA isolates obtained from patients in three tertiary hospitals. Materials and Methods: In total, 22 CC30-MSSA isolates cultured from different clinical samples were investigated using antibiotic sensitivity testing, spa typing, multilocus sequence typing and DNA microarray analysis. Results: All 22 isolates were susceptible to vancomycin (MIC ≤ 2 μg/ml), teicoplanin (MIC ≤ 2 μg/ml) and cefoxitin but were resistant to penicillin G (n=22; 100.0%), tetracycline (n=12; 54.5%), ciprofloxacin (n=15; 68.2%), cadmium acetate (n=22; 100%), mercuric chloride (n=13; 59.1%), and ethidium bromide (n=3; 13.6%). The isolates belonged to sequence type, ST30, and five spa types; t012 (n=12; 54.5%), t019 (n=5; 22.7%), t017 (n=2; 9.1%), t037 (n=2; 9.1%) and t318 (n=1; 4.5%). All 22 isolates were positive for agrIII, cap8, clfA, clfB, icaA, icaC, icaD, cna and staphylococcal enterotoxin gene clusters (seg, sei, sem, sen, seo, seu). Eight isolates carried lukS-PV and lukF-PV that code for Panton-Valentine leukocidin. Conclusion: The current CC30-MSSA isolates shared phenotypic and genotypic characteristics with the pandemic phage 80/81 isolates that were common in the 1950s and 1960s. Continued surveillance is recommended to keep abreast of the changing epidemiology of S. aureus causing healthcare and community-associated infections.